Researchers have discovered that mimicking cold exposure or fasting can trigger an immune response in the body that slows ...

Detailed price information for Avalo Therapeutics Inc (AVTX-Q) from The Globe and Mail including charting and trades.

ARCALYST- (rilonacept) 2025 net product revenue of $677.5 million (unaudited), representing ~62% year-over-year growth -- ARCALYST 2026 net product revenue expected to be $900 - $920 million -- KPL-38 ...

The biotechnology sector offers investors a high-risk, high-reward opportunity as companies race to bring breakthrough ...

CK0804, a regulatory T cell therapy, received FDA orphan drug designation for myelofibrosis, supporting rare disease treatment development. Clinical study results showed significant reductions in ...

New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung repair, and improved lung function LA JOLLA, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) ...

Type 1 Diabetes (T1D) is a severe autoimmune disorder marked by the immune system's targeted destruction of pancreatic beta ...

elementaryOS 8.1 adds polish to an already elegant OS. The focus is on security, multitasking, and app management. It's in beta, with no public release date yet. When I received word from Danielle ...

Even though the game is currently in early access, Schedule 1 updates are constantly being released. Many users may not be aware, however, that by changing to the beta version of the game on Steam, ...

Google’s last couple of QPR updates for Android 16 have been nothing short of incredible. QPR1 brought Google’s excellent Material 3 Design UI to Pixel phones, while this month’s QPR2 update added new ...

A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...

Rajesh started following the latest happenings in the world of Android around the release of the Nexus One and Samsung Galaxy S. After flashing custom ROMs and kernels on his beloved Galaxy S, he ...